Announcements Trials

Browse Landscape Eligibility

Clinical Trials

1 trials

Recent Start date Enrollment

Active not recruiting × Neurofibrosarcoma × sotigalimab × Clear all

Phase

Status

Active not recruiting 1

Sponsor Class

Study Type

Interventional 1

Sponsor

Cancer Type

Conditions

Sarcoma, Synovial 1 Sarcoma 1 Neurofibrosarcoma 1 Locally Advanced Rectal Adenocarcinoma 1 Liposarcoma 1 Leiomyosarcoma 1 Colorectal Neoplasms 1 Carcinoma, Renal Cell 1

Interventions

Nivolumab 2 Doxorubicin 2 tazemetostat 1 sotigalimab 1 pembrolizumab 1 pazopanib 1 Specimen Handling 1 Radiotherapy 1 Radiation 1 Magnetic Resonance Spectroscopy 1 Ipilimumab 1 Ifosfamide 1 CTLA-4 Antigen 1

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

NCT03719430 2025-04-29

APX005M and Doxorubicin in Advanced Sarcoma

Columbia University

Phase 2 Active not recruiting

Leiomyosarcoma, Liposarcoma, Sarcoma, Sarcoma, Synovial, Neurofibrosarcoma

Data powered by HemOnc (CC BY 4.0) Colophon ⚡